相关实验视频

Updated: Sep 17, 2025

A Novel Three-dimensional Flow Chamber Device to Study Chemokine-directed Extravasation of Cells Circulating under Physiological Flow Conditions

A Novel Three-dimensional Flow Chamber Device to Study Chemokine-directed Extravasation of Cells Circulating under Physiological Flow Conditions

Published on: July 15, 2013

血管内皮生长因子诱导的血管透性导致激烈和可逆的造血干细胞动员

Stephanie Smith-Berdan¹, Mark Landon¹, Bryan Petkus¹

¹Institute for the Biology of Stem Cells, Department of Biomolecular Engineering, University of California-Santa Cruz, Santa Cruz, CA 95064, USA.

Stem cell reports

|June 27, 2025

概括

血管内皮生长因子A (VEGF-A) 通过增加血管透性,迅速和可逆地调动造血干细胞 (HSC). 动员的HSCs保持功能,改善移植结果和骨髓位完整性.

科学领域:

血液学血液学血液学
血管生物学血管生物学
干细胞生物学干细胞生物学

背景情况:

血液形成干细胞 (HSC) 通过骨髓内皮进行贩运,对于血液形成和移植至关重要.
血管透性调节器越来越被认为是高血压细胞位置的关键控制器.

研究的目的:

研究血管内皮生长因子A (VEGF-A) 对HSC动员和骨髓血管完整性的影响.
评估 VEGF 动员的 HSC 的功能性和植入潜力.

主要方法:

利用可诱导多西环素的小鼠模型过度表达VEGF-A,调节血管透性.
分析了HSC在血液中的动员.
通过对被照射受体进行长期多谱系复制试验来评估HSC功能.
在移植后对VEGF过度表达的接受者进行骨髓位完整性和HSC移植的评估.

主要成果:

在没有额外的药物的情况下,VEGF-A过度表达诱导了从骨髓到血液中的快速,可逆的HSC动员.
动员的HSC表现出强大的长期多谱系复合能力.
由VEGF诱导的血管透性并没有对骨髓血管造成不可逆转的损伤.
过度表达VEGF的接受者显示长期改善了供体HSC的移植.

结论:

VEGF-A是一种强效的,非侵入性调节器的高糖贩运.
由VEGF诱导的透性增强了HSC的动员,并提高了移植的有效性.
这种方法为在临床环境中调节高血小细胞提供了一个有希望的策略,有可能改善造血干细胞疗法.

关键词:

在HSC的植入过程中,在HSC的动员行动中.这就是HSC贩卖的原因.在VEGF中,VEGF是VEGF.骨髓内皮质骨髓内皮质造血干细胞造血干细胞造血细胞移植疗法造血细胞移植疗法鼠标模型鼠标模型鼠标模型移植移植移植移植血管内皮生长因子血管内皮生长因子血管的位置是血管.血管透性的血管透性

更多相关视频

Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery

Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery

Published on: February 14, 2017

Isolation of Murine Embryonic Hemogenic Endothelial Cells

Isolation of Murine Embryonic Hemogenic Endothelial Cells

Published on: June 17, 2016

相关概念视频

Regulation of Hematopoietic Stem Cells

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...

Multipotency of Hematopoietic Stem Cells

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...

Role of Hematopoietic Growth Factors

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...

Hematopoiesis

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...

Mechanism of Angiogenesis

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...